5-Fluorouracil, Cyclophosphamide, and Vincristine for Adenoid Cystic Carcinoma of the Head and Neck
β Scribed by Pierre L. Triozzi; Alton Brantley; Samuel Fisher; T. Boyce Cole; Ian Crocker; Andrew T. Huang
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 426 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty-six patients with squamous cell carcinoma of the head and neck were treated with sequential methotrexate-5-fluorouracil followed by leucovorin rescue. The frequency of objective tumor regression obtained was 64% (complete response + partial response) with 19% complete regression. In 20 not pr
## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi